  Diseased conditions are a consequence of some abnormality that are associated
with clinical conditions in numerous cells and tissues affecting various
organs. The common role of EBV (Epstein-Barr virus) in causing infectious
mononucleosis (IM) affecting B-cells and epithelial cells and the development
of EBV-associated cancers has been an area of active research. Investigating
such significant interactions may help discover new therapeutic targets for
certain EBV-associated lymphoproliferative (Burkitt's Lymphoma and Hodgkin's
Lymphoma) and non-lymphoproliferative diseases (Gastric cancer and
Nasopharyngeal cancer). Based on the DisGeNET (v7.0) data set, we constructed a
disease-gene network bipartite graph to identify genes that are involved in
various carcinomas namely, gastric cancer (GC), nasopharyngeal cancer (NPC),
Hodgkin's lymphoma (HL) and Burkitt's lymphoma (BL). Using the community
detection algorithm (Louvain method), we identified communities followed by
functional enrichment using over-representation analysis methodology. In this
study, we identified the modular communities to explore the relation of this
common causative pathogen (EBV) with different carcinomas such as GC, NPC, HL
and BL. We could identify the top 10 genes as CASP10, BRAF, NFKBIA, IFNA2,
GSTP1, CSF3, GATA3, UBR5, AXIN2 and POLE based on their degree of distribution.
Further over-representation analysis showed that the ABL1 gene was
significantly over-represented in 3 out of 9 critical biological processes. As
a result, we can infer that the EBV pathogen is selective in targeting critical
pathways to bring about cellular growth arrest/apoptosis and interfering with
vital biological processes, including the TP53 network of genes that leads to
further proliferation of damage to vital cellular activities.
